Eurazeo Balance Sheet Health
Financial Health criteria checks 3/6
Eurazeo has a total shareholder equity of €7.9B and total debt of €1.1B, which brings its debt-to-equity ratio to 14.2%. Its total assets and total liabilities are €9.6B and €1.6B respectively. Eurazeo's EBIT is €282.0K making its interest coverage ratio 0. It has cash and short-term investments of €137.9M.
Key information
14.2%
Debt to equity ratio
€1.13b
Debt
Interest coverage ratio | 0.004x |
Cash | €137.90m |
Equity | €7.94b |
Total liabilities | €1.65b |
Total assets | €9.59b |
Recent financial health updates
No updates
Recent updates
What You Need To Know About The Eurazeo SE (EPA:RF) Analyst Downgrade Today
Sep 18Need To Know: The Consensus Just Cut Its Eurazeo SE (EPA:RF) Estimates For 2024
Aug 01If EPS Growth Is Important To You, Eurazeo (EPA:RF) Presents An Opportunity
Feb 06There Is A Reason Eurazeo SE's (EPA:RF) Price Is Undemanding
Jan 02Does Eurazeo (EPA:RF) Deserve A Spot On Your Watchlist?
Nov 06Should You Be Adding Eurazeo (EPA:RF) To Your Watchlist Today?
Jul 30We Ran A Stock Scan For Earnings Growth And Eurazeo (EPA:RF) Passed With Ease
Jan 18Here's Why We Think Eurazeo (EPA:RF) Is Well Worth Watching
Aug 07Should Eurazeo SE (EPA:RF) Be Part Of Your Income Portfolio?
Mar 31Investors Who Bought Eurazeo (EPA:RF) Shares Five Years Ago Are Now Up 48%
Feb 09What Can We Make Of Eurazeo's (EPA:RF) CEO Compensation?
Dec 18Financial Position Analysis
Short Term Liabilities: RF's short term assets (€481.1M) do not cover its short term liabilities (€1.3B).
Long Term Liabilities: RF's short term assets (€481.1M) exceed its long term liabilities (€321.8M).
Debt to Equity History and Analysis
Debt Level: RF's net debt to equity ratio (12.5%) is considered satisfactory.
Reducing Debt: RF's debt to equity ratio has reduced from 53.9% to 14.2% over the past 5 years.
Debt Coverage: RF's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: RF's interest payments on its debt are not well covered by EBIT (0x coverage).